WEC
CMD

Winslow Evans & Crocker’s Cantel Medical Corporation CMD Stock Holding History

Winslow Evans & Crocker’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-22
Closed -$2K – 1396
2019
Q1 		$2K Buy
+22
New +$1.67K ﹤0.01% 1308

Other funds holding CMD

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Winslow Evans & Crocker's CMD Position: Q2 2019 in Review

Winslow Evans & Crocker sold out of Cantel Medical Corporation (CMD) in Q2 2019, closing a stake of 22 shares — an estimated $2K sold.

Winslow Evans & Crocker first reported a position in CMD in Q1 2019 and held it in 1 quarter. The position peaked at $2K in Q1 2019. 242 funds tracked by Wall St. Rank hold CMD as of Q2 2019.

  • Winslow Evans & Crocker reported no remaining Cantel Medical Corporation position as of Q2 2019 after selling out during the quarter.
  • Winslow Evans & Crocker sold 22 Cantel Medical Corporation shares in Q2 2019, an estimated $2K.
  • Winslow Evans & Crocker first reported a position in Cantel Medical Corporation in Q1 2019 and held it in 1 quarter.
  • Winslow Evans & Crocker's Cantel Medical Corporation position peaked at $2K in Q1 2019.
  • 242 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2019.

Based on Winslow Evans & Crocker's 13F filing for Q2 2019, filed 19 Jul 2019.